Intensive treatment with atorvastatin significantly reduced ET-1 serum level.
Intensive treatment with atorvastatin also achieved a greater reduction of MA-ADP.
ET-1 serum levels were positively correlated with MA-ADP after Intensive treatment.
Patients in intensive group appeared to suffer from less cardiovascular events.